Pharmaceutical Technology, Outsourcing Resources Supplement 2012 (PDF)
Outsourcing Resources
A Manufacturing Capacity-Sharing Model: Merck & Co. and MedImmune LLC
The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition".
Size Associations in the CRO Outsourcing Relationship
The author provides results and commentary on a survey analyzing outsourcing strategies, practices, challenges, and outcomes in the selection of a CRO.
Market Strengths and Weaknesses in Biosimilars
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
Quality by Design: A Contract Organization's Perspective
The author discusses how a CDMO helps in gaining process understanding and in developing robust, high-quality products and processes.
Strategies in Outsourcing Facilities Management
The authors highlight costs, benefits, and implementation success factors across first, second, and third generations of facility management outsourcing contracts.
Strategies in Outsourcing: Insourcing Emerges as an Alternative Model
AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly.
CROs and CMOs Have Cause to Celebrate
Annual survey shows strong growth for service providers and promises to continue into 2013.
